Reaction profile

The FDA adverse-event record for oral dryness

12 FDA reports name oral dryness, a lower-volume reaction in the CVM extract (VeDDRA 294). Plate stamps and neighbourhood peers follow.

#2393 of 2,481
by report volume (all reactions)
12
reports citing this reaction
16.7%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Oral dryness has 12 reports now versus 12 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Oral dryness changes

FDA AER · VeDDRA plate

Code 294 VOL-TRACE

VOL-TRACE · DEATH-ELEV · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 12 reports
  • DEATH-ELEV 16.7%
  • BOTTOM-DECILE #2393/2481
  • PHOTO-FINISH Agitated state of mind
  • SPECIES-DOG Dog · 9
  • DRUG-LEAD Deracoxib · 2
  • DESK-WIDE 11 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Agitated state of mind (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Oral dryness

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Agitated state of mind · near12Airsacculitis · near12Anal prolapse · near12Anal sac adenocarcioma · near12Oral dryness · this reaction12Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Oral dryness

What the FDA AER plate says about Oral dryness

Signature read: 12 reports place Oral dryness in the lower third of FDA AER volume (#2393 of 2,481). Report volume is lower-third scale: 12 named reports in the openFDA extract. 2 of 12 reports were death-coded (16.7% of named reports, not a population mortality rate). Nearest volume peer: Agitated state of mind (±0 reports). Lead species Dog (9). Lead co-reported drug Deracoxib (2).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Deracoxib appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 9
Cat 2
Human 1

Breeds Most Affected

Crossbred Canine/dog 2
Retriever - Golden 1
Dog (other) 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Terrier - Yorkshire 1
Bengal 1
Bloodhound 1
Mountain Dog - Bernese 1
Unknown 1
Shih Tzu 1

Associated Drugs

Deracoxib 2
Feline Viral Rhinotracheitis, Calicivirus, Panleukopenia And Chlamydiosis Vaccine 2
Dexamethasone 2
Maropitant Citrate 2
Mirtazapine 2
Spinosad 2
Trazodone 2
Fluoxetine 2
Amoxicillin Trihydrate; Clavulanate Potassium ( K-Clavulanate) 1
Levothyroxine Sodium 1
Firocoxib 227 Mg Chewable 1
Amoxicillin 1
Gentamicin/ Betamethasone/ Clotrimazole 1
Ivermectin/Pyrantel 1
Dimenhydrinate 1
Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg 1
Recombitek C4 - 13D1.R1 1
Imrab 3 Tf - 1905.23 1
Ivermectin/Pyrantel Pamoate Chewable 272Mcg/652Mg 1
Emodepside + Praziquantel 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Oral dryness (#2393 of 2,481 by report volume); death-coded 16.7%. PlainBreed reaction plate · report volume stamp 12 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →